MRSN(Delisted)
Mersana Therapeutics·NASDAQ
--
--(--)
4.99 / 10
Netural
Fund flow analysis scores 7.44/10, indicating robust fund flow characteristics. Bullish trends in Small contrast with bearish signals in overall, block, Medium, Large, and Extra-large, suggesting positive liquidity momentum. Professional analyst opinion suggests divided analyst consensus, showing neutral perspective. Distribution pattern: Neutral(100.0%) based on 3 research evaluations, supported by 2.54 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-13
InstitutionTruist Securities
Times predicted3
Historical Win Rate66.7%
What is the market sentiment for MRSN?
- MRSN holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.99/10 (Netural).
